Institutional Fund
Kalehua Capital Management LLC
Dallas, TXCIK 21061813 filings on record
Portfolio Value
$141.34M
Q1 2026
Holdings
25
Reported positions
New Buys
9
Opened this quarter
QoQ Change
+39.8%
from $101.10M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Ea Series Trust18.0%
- X4 Pharmaceuticals Inc10.9%
- Surrozen Inc7.9%
- Veradermics Inc6.5%
- Relay Therapeutics Inc6.3%
- Sionna Therapeutics Inc5.6%
- Other44.8%
Portfolio Holdings
25 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Ea Series Trust | 218.3K | $25.38M | 18.0% | −12.5K | Reduced |
| 2 | X4 Pharmaceuticals Inc | 3.72M | $15.38M | 10.9% | 0 | Held |
| 3 | Surrozen Inc | 385.2K | $11.22M | 7.9% | 0 | Held |
| 4 | Veradermics Inc | 145.7K | $9.20M | 6.5% | +145.7K | New |
| 5 | Relay Therapeutics Inc | 901.5K | $8.97M | 6.3% | 0 | Held |
| 6 | Sionna Therapeutics Inc | 197.1K | $7.90M | 5.6% | 0 | Held |
| 7 | Aclaris Therapeutics Inc | 1.83M | $6.87M | 4.9% | +1.83M | New |
| 8 | Inhibikase Therapeutics Inc | 3.82M | $6.42M | 4.5% | +2.07M | Added |
| 9 | Oruka Therapeutics Inc | 118.5K | $5.81M | 4.1% | 0 | Held |
| 10 | Pharvaris N V | 198.8K | $5.62M | 4.0% | 0 | Held |
15 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio